Skip to content

环球人寿

US · GL #1263 按市值排名 上市于 1970
168.77 +1.18 +0.70%
实时 - 追踪5344个代码 - 心跳于242秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期（2026/Q3）披露持股的机构数量减少了3家。
  • 机构持股总比例上升了0.1个百分点。

机构持股

机构持股比例
86.19% +0.13pp
机构数量
822 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund73.59%
Hedge Fund4.83%
Public Company3.22%
Government Pension Fund1.41%
Sovereign Wealth Fund1.20%
Private Company1.20%
Individual/Insider0.83%
Family Office/Trust0.32%
Insurance Company0.20%
Other13.21%

主要股东 截至 2026-06-30

BlackRock 7.19% · 5.53M 股
Vanguard Capital Management, LLC 7.18% · 5.52M 股
Vanguard Portfolio Management, LLC 5.44% · 4.18M 股
State Street Global Advisors 4.86% · 3.74M 股
Invesco Ltd. 3.69% · 2.84M 股
Geode Capital Management, LLC 3.65% · 2.80M 股
Dimensional Fund Advisors 3.11% · 2.39M 股
Invesco Capital Management LLC 2.32% · 1.78M 股
Eaton Vance Management 1.96% · 1.51M 股
AQR Capital Management 1.93% · 1.48M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 9次买入 · 41次卖出

姓名职务持股比例
Frank Svoboda Co-Chairman & Co-CEO 0.25%
Robert Mitchell Executive VP, General Counsel & Chief Risk Officer 0.09%
James Darden Co-Chairman & Co-CEO 0.08%
Michael Majors Executive VP of Policy Acquisition & Chief Strategy Officer 0.07%
Thomas Kalmbach Chief Financial Officer 0.07%
Jennifer Haworth Chief Marketing Officer 0.03%
Marilyn Alexander Independent Director 0.03%
Linda Addison Lead Independent Director 0.03%
Mary Thigpen Independent Director 0.02%
Rebecca Zorn Executive VP & Chief Talent Officer 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-21 Robert Hensley Executive VP & Chief Investment Officer Derivative Exercise and Sale -10,000 $103.23–170.34
2026-08-13 Frank Svoboda Co-Chairman & Co-CEO Intent to Sell (Form 144) -16,500 $177.91
2026-08-06 Robert Mitchell Executive VP, General Counsel & Chief Risk Officer Derivative Exercise and Sale -23,000 $103.23–184.75
2026-08-04 Robert Mitchell Executive VP, General Counsel & Chief Risk Officer Intent to Sell (Form 144) -23,000 $183.90
2026-07-30 James Darden Co-Chairman & Co-CEO Derivative Exercise and Sale -50,000 $98.32–183.36
2026-07-29 Thomas Kalmbach Chief Financial Officer Derivative Exercise and Sale -21,000 $103.23–181.81
2026-07-28 Michael Majors Executive VP of Policy Acquisition & Chief Strategy Officer Derivative Exercise and Sale -37,000 $103.23–179.35
2026-07-27 Thomas Kalmbach Chief Financial Officer Derivative Exercise and Sale -25,650 $120.49–179.42
2026-07-26 Thomas Kalmbach Chief Financial Officer Intent to Sell (Form 144) -46,650 $173.48
2026-07-23 Michael Majors Executive VP of Policy Acquisition & Chief Strategy Officer Intent to Sell (Form 144) -37,000 $171.08
2026-06-29 Dolores Skarjune Executive Vice President Derivative Exercise and Sale -1,850 $103.23–179.18
2026-06-24 Cheryl Alston Independent Director Derivative Exercise and Sale -8,258 $105.56–180.57
2026-06-24 Cheryl Alston Independent Director Derivative Exercise and Retained +5,759 $105.56
2026-06-17 Rebecca Zorn Executive VP & Chief Talent Officer Derivative Exercise and Sale -2,000 $98.32–170.10
2026-06-14 Cheryl Alston Independent Director Intent to Sell (Form 144) -14,017 $166.76
2026-06-11 Frank Svoboda Co-Chairman & Co-CEO Derivative Exercise and Sale -20,000 $100.74–166.93
2026-06-11 Robert Mitchell Executive VP, General Counsel & Chief Risk Officer Other Disposition -1,250 --
2026-06-11 Dolores Skarjune Executive Vice President Derivative Exercise and Sale -4,175 $98.32–167.25
2026-06-10 Frank Svoboda Co-Chairman & Co-CEO Intent to Sell (Form 144) -25,000 $159.18
2026-05-28 Robert Mitchell Executive VP, General Counsel & Chief Risk Officer Open Market Disposition -600 $155.55–155.57

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

环球人寿 讨论区 0 条评论

发表评论